RJA
IMAX icon

Ross\Johnson & Associates’s IMAX IMAX Stock Holding History

Ross\Johnson & Associates’s Portfolio IMAX Stock Details IMAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-5
Closed -$185 – 281
2025
Q4 		$185 Buy
+5
New +$174 ﹤0.01% 254

Other funds holding IMAX

OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ross\Johnson & Associates's IMAX Position: Q1 2026 in Review

Ross\Johnson & Associates sold out of IMAX (IMAX) in Q1 2026, closing a stake of 5 shares — an estimated $185 sold.

Ross\Johnson & Associates first reported a position in IMAX in Q4 2025 and held it in 1 quarter. The position peaked at $185 in Q4 2025. 254 funds tracked by Wall St. Rank hold IMAX as of Q1 2026.

  • Ross\Johnson & Associates reported no remaining IMAX position as of Q1 2026 after selling out during the quarter.
  • Ross\Johnson & Associates sold 5 IMAX shares in Q1 2026, an estimated $185.
  • Ross\Johnson & Associates first reported a position in IMAX in Q4 2025 and held it in 1 quarter.
  • Ross\Johnson & Associates's IMAX position peaked at $185 in Q4 2025.
  • 254 funds tracked by Wall St. Rank held IMAX as of Q1 2026.

Based on Ross\Johnson & Associates's 13F filing for Q1 2026, filed 8 May 2026.